Role of serum thyroglobulin as a surrogate marker in evaluating outcome following radioiodine therapy in differentiated thyroid cancer

被引：0
|
作者：
Pradhan, Prasanta [2 ]
Mammoottil, Alen [2 ]
Gambhir, Sanjay [2 ]
Mishra, Saroj [1 ]
Mishra, Anjali [1 ]
机构：
[1] SGPGIMS, Endosurg, Lucknow, Uttar Pradesh, India
[2] SGPGIMS, Nucl Med, Lucknow, Uttar Pradesh, India
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1537
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Serum thyroglobulin concentration after rhTSH stimulation as a prognostic factor during adjuvant radioiodine treatment of differentiated thyroid cancer
    Handkiewicz-Junak, D.
    Ledwon, A.
    Kropinska, A.
    Roskosz, J.
    Paliczka-Cieslik, E.
    Puch, Z.
    Gawlik, T.
    Olczyk, T.
    Jarzab, B.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S364 - S364
  • [42] Thyroglobulin Flare Response After Radioiodine Ablation in 2 Patients With Differentiated Thyroid Cancer
    Tsang, James F.
    Levin, Daniel P.
    Leslie, William D.
    [J]. CLINICAL NUCLEAR MEDICINE, 2015, 40 (05) : 421 - 422
  • [43] Prognostic value of an increase in the serum thyroglobulin level at the time of the first ablative radioiodine treatment in patients with differentiated thyroid cancer
    Marie-Odile Bernier
    Olivier Morel
    Patrice Rodien
    Jean-Pierre Muratet
    Philippe Giraud
    Vincent Rohmer
    Christian Jeanguillaume
    Jean-Claude Bigorgne
    Pierre Jallet
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2005, 32 : 1418 - 1421
  • [44] Prognostic value of serum thyroglobulin determinations before radioiodine ablation in patients with differentiated thyroid carcinoma
    Rodrigues, F.
    Martinho, M.
    Curado, F.
    Cunha, N.
    Cruz, C.
    Ganho, J.
    Naidenov, A.
    Neto, J.
    Oliveira, S.
    Pereira, J.
    Valido, F.
    Campos, B.
    [J]. HORMONE RESEARCH, 2007, 68 : 41 - 42
  • [45] MANAGEMENT OF PATIENTS WITH DIFFERENTIATED THYROID-CANCER WHO HAVE POSITIVE SERUM THYROGLOBULIN LEVELS AND NEGATIVE RADIOIODINE SCANS
    CLARK, OH
    HOELTING, T
    [J]. THYROID, 1994, 4 (04) : 501 - 505
  • [46] Prognostic Value of Stimulated Thyroglobulin Levels at the Time of Radioiodine Administration in Differentiated Thyroid Cancer
    Spaas, Mathieu
    Decallonne, Brigitte
    Laenen, Annouschka
    Billen, Jaak
    Nuyts, Sandra
    [J]. EUROPEAN THYROID JOURNAL, 2018, 7 (04) : 211 - 217
  • [47] Radioiodine as an adjuvant therapy and its role in follow-up of differentiated thyroid cancer
    Padma, S.
    Sundaram, P. Shanmuga
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (03) : 1109 - 1113
  • [48] Postoperative thyroid remnants for differentiated thyroid cancer may not affect the outcome of high-dose radioiodine therapy
    Pan, Liqin
    Chen, Yanying
    Li, Sixiao
    Ouyang, Wei
    Feng, Huijuan
    Wu, Juqing
    Chen, Pan
    Deng, Yuying
    Wang, Jing
    Luo, Jiaxin
    Xian, Jialan
    [J]. ORAL ONCOLOGY, 2020, 104
  • [49] Radioiodine Therapy in Differentiated Thyroid Cancer: The First Targeted Therapy in Oncology
    Chung, June-Key
    Cheon, Gi Jeong
    [J]. ENDOCRINOLOGY AND METABOLISM, 2014, 29 (03) : 233 - 239
  • [50] Retrospective Analysis of Radioiodine Therapy for Differentiated Thyroid Cancer Patients
    Gunes, B.
    Demir, M.
    Kanmaz, B.
    Kabasakal, L.
    Sayman, H.
    Onsel, C.
    Uslu, I.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S446 - S446
12345